rs201072665

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_ModerateBP6_Very_StrongBS2

The NM_012281.3(KCND2):​c.670C>A​(p.Arg224Arg) variant causes a synonymous change. The variant allele was found at a frequency of 0.000785 in 1,613,782 control chromosomes in the GnomAD database, including 15 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.00051 ( 2 hom., cov: 31)
Exomes 𝑓: 0.00081 ( 13 hom. )

Consequence

KCND2
NM_012281.3 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 4.04

Publications

0 publications found
Variant links:
Genes affected
KCND2 (HGNC:6238): (potassium voltage-gated channel subfamily D member 2) Voltage-gated potassium (Kv) channels represent the most complex class of voltage-gated ion channels from both functional and structural standpoints. Their diverse functions include regulating neurotransmitter release, heart rate, insulin secretion, neuronal excitability, epithelial electrolyte transport, smooth muscle contraction, and cell volume. Four sequence-related potassium channel genes - shaker, shaw, shab, and shal - have been identified in Drosophila, and each has been shown to have human homolog(s). This gene encodes a member of the potassium channel, voltage-gated, shal-related subfamily, members of which form voltage-activated A-type potassium ion channels and are prominent in the repolarization phase of the action potential. This member mediates a rapidly inactivating, A-type outward potassium current which is not under the control of the N terminus as it is in Shaker channels. [provided by RefSeq, Jul 2008]
KCND2 Gene-Disease associations (from GenCC):
  • KCND2-related neurodevelopmental disorder with or without seizures
    Inheritance: AD Classification: MODERATE Submitted by: G2P
  • complex neurodevelopmental disorder
    Inheritance: AD Classification: LIMITED Submitted by: Illumina

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.24).
BP6
Variant 7-120275302-C-A is Benign according to our data. Variant chr7-120275302-C-A is described in ClinVar as Benign. ClinVar VariationId is 529732.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS2
High AC in GnomAd4 at 78 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
KCND2NM_012281.3 linkc.670C>A p.Arg224Arg synonymous_variant Exon 1 of 6 ENST00000331113.9 NP_036413.1
KCND2XM_047420346.1 linkc.670C>A p.Arg224Arg synonymous_variant Exon 2 of 7 XP_047276302.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
KCND2ENST00000331113.9 linkc.670C>A p.Arg224Arg synonymous_variant Exon 1 of 6 1 NM_012281.3 ENSP00000333496.4

Frequencies

GnomAD3 genomes
AF:
0.000514
AC:
78
AN:
151790
Hom.:
2
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.0000726
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000722
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000195
Gnomad SAS
AF:
0.00980
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000221
Gnomad OTH
AF:
0.000479
GnomAD2 exomes
AF:
0.00138
AC:
347
AN:
251430
AF XY:
0.00197
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.0000578
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000158
Gnomad OTH exome
AF:
0.000977
GnomAD4 exome
AF:
0.000813
AC:
1189
AN:
1461874
Hom.:
13
Cov.:
32
AF XY:
0.00118
AC XY:
858
AN XY:
727246
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
33480
American (AMR)
AF:
0.0000894
AC:
4
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26136
East Asian (EAS)
AF:
0.000252
AC:
10
AN:
39700
South Asian (SAS)
AF:
0.0110
AC:
946
AN:
86258
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53408
Middle Eastern (MID)
AF:
0.00277
AC:
16
AN:
5768
European-Non Finnish (NFE)
AF:
0.000152
AC:
169
AN:
1112004
Other (OTH)
AF:
0.000729
AC:
44
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.459
Heterozygous variant carriers
0
84
168
253
337
421
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000513
AC:
78
AN:
151908
Hom.:
2
Cov.:
31
AF XY:
0.000754
AC XY:
56
AN XY:
74246
show subpopulations
African (AFR)
AF:
0.0000724
AC:
3
AN:
41428
American (AMR)
AF:
0.000721
AC:
11
AN:
15264
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.000196
AC:
1
AN:
5110
South Asian (SAS)
AF:
0.00980
AC:
47
AN:
4794
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10570
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000221
AC:
15
AN:
67960
Other (OTH)
AF:
0.000474
AC:
1
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.479
Heterozygous variant carriers
0
4
8
11
15
19
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000313
Hom.:
0
Bravo
AF:
0.000242
Asia WGS
AF:
0.00231
AC:
8
AN:
3478
EpiCase
AF:
0.000436
EpiControl
AF:
0.000178

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:1
Jan 27, 2025
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant summary: KCND2 c.670C>A alters a conserved nucleotide resulting in a synonymous change. Several computational tools predict a significant impact on normal splicing: Four predict the variant abolishes a cryptic 5' donor site. However, these predictions have yet to be confirmed by functional studies. The variant allele was found at a frequency of 0.0014 in 251430 control chromosomes in the gnomAD database, including 6 homozygotes. The observed variant frequency is approximately 221 fold of the estimated maximal expected allele frequency for a pathogenic variant in KCND2 causing Arrhythmia phenotype (6.3e-06). To our knowledge, no occurrence of c.670C>A in individuals affected with Arrhythmia and no experimental evidence demonstrating its impact on protein function have been reported. ClinVar contains an entry for this variant (Variation ID: 529732). Based on the evidence outlined above, the variant was classified as benign. -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Early myoclonic encephalopathy Benign:1
Jan 22, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.24
CADD
Benign
12
DANN
Benign
0.59
PhyloP100
4.0
Mutation Taster
=94/6
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs201072665; hg19: chr7-119915356; API